✦ LIBER ✦

Targeted kinase inhibitors in lung cancer: From EGFR to patients

✍ Scribed by Giovanni Apolone; Carlo La Vecchia; Silvio Garattini

Book ID: 116428798
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 82 KB
Volume: 42
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2005.10.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Identification of EGFR kinase domain mut

Identification of EGFR kinase domain mutations among lung cancer patients in China: implication for targeted cancer therapy

✍ QIN, Bao Ming; CHEN, Xiao; ZHU, Jing De; PEI, Duan Qing 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 187 KB

Lessons learnt from gefitinib and erloti

Lessons learnt from gefitinib and erlotinib: Key insights into small-molecule EGFR-targeted kinase inhibitors in non-small cell lung cancer

✍ Laack, Eckart; Sauter, Guido; Bokemeyer, Carsten 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 219 KB

MET gene amplification or EGFR mutation

MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors

✍ Takafumi Kubo; Hiromasa Yamamoto; William W. Lockwood; Ilse Valencia; Junichi So 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 315 KB

## Abstract We analyzed __MET__ protein and copy number in NSCLC with or without __EGFR__ mutations untreated with EGFR tyrosine kinase inhibitors (TKIs). __MET__ copy number was examined in 28 NSCLC and 4 human bronchial epithelial cell lines (HBEC) and 100 primary tumors using quantitative real‐t

Activating and resistance mutations of E

Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors

✍ Gazdar, A F 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 213 KB

757 Loss of IGF-binding Protein 3 of EGF

757 Loss of IGF-binding Protein 3 of EGFR Mutant Lung Cancer Cells in Acquired Resistance to EGFR-tyrosine Kinase Inhibitor

✍ C.M. Choi; H.Y. Kim; Y.S. Park; J.C. Lee 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Timing of Epidermal Growth Factor Recept

Timing of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Patients With Lung Cancer With EGFR Mutations

✍ Moran, T.; Sequist, L. V. 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 202 KB